GRAFT is scheduled to get FDA approval in CY2025.
- Forums
- IPOs
- ReNerve IPO
GRAFT is scheduled to get FDA approval in CY2025.
Featured News
Featured News
The Watchlist
AFP
AFT PHARMACEUTICALS LIMITED
Hartley Atkinson, CEO & Founder
Hartley Atkinson
CEO & Founder
Previous Video
Next Video
SPONSORED BY The Market Online